Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pharmacology and Obesity Treatment
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the pharmacological management of obesity, including the use of anti-obesity drugs, clinical trials evaluating their efficacy and safety, and the impact on weight loss. It covers a wide range of medications such as sibutramine, orlistat, and ephedra alkaloids, as well as their associated adverse events and lipase inhibitors.
210
Works
IDs:OpenAlex
How has Pharmacology and Obesity Treatment's publication output changed over time?
ScholarIQpublication output · 2004–2021
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2021.
1
1
1
2
1
1
2
1
1
1
2004200520082011201420152016201820202021
What are the most-cited papers on Pharmacology and Obesity Treatment?
ScholarIQmost cited works
Valvular Heart Disease Associated with Fenfluramine–Phentermine
Heidi M. Connolly, Jack L. Crary, Michael D. McGoon, Donald D. Hensrud, Brooks S. Edwards, William D. Edwards, Hartzell V. Schaff
New England Journal of Medicine. 19971,639 CitationsOPEN ACCESS
Obesity in adults: a clinical practice guideline
Sean Wharton, David C.W. Lau, Michael Vallis, Arya M. Sharma, Laurent Biertho, Denise Campbell‐Scherer, Kristi B. Adamo, Angela S. Alberga, Rhonda C. Bell, Normand G. Boulé, Elaine Boyling, Jennifer Brown, Betty Calam, Carol Clarke, Lindsay Crowshoe, Dennis DiValentino, Mary Forhan, Yoni Freedhoff, Michel Gagner, Stephen Glazer, C. G. Grand, Michael Green, Margaret Hahn, Raed Hawa, Rita Henderson, Dennis Hong, Pam Hung, Ian Janssen, Kristen Jacklin, Carlene Johnson Stoklossa, Amy Kemp, Sara Kirk, Jennifer L. Kuk, Marie‐France Langlois, Scott A. Lear, Ashley McInnes, David Macklin, Leen Naji, Priya Manjoo, Marie‐Philippe Morin, Kara Nerenberg, Ian Patton, Sue D. Pedersen, Leticia Pereira, Helena Piccinini‐Vallis, Megha Poddar, Paul Poirier, Denis Prud’homme, Ximena Ramos Salas, Christian F. Rueda‐Clausen, Shelly Russell‐Mayhew, Judy Shiau, Diana Sherifali, John L. Sievenpiper, Sanjeev Sockalingam, Valerie H. Taylor, Ellen L. Toth, Laurie Twells, Richard Tytus, Shahebina Walji, Leah Walker, Sonja Wicklum
Canadian Medical Association Journal. 20201,472 CitationsOPEN ACCESS
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie E. McDonnell, M. Hassan Murad, Uberto Pagotto, Donna H. Ryan, Christopher D. Still
The Journal of Clinical Endocrinology & Metabolism. 20151,322 CitationsOPEN ACCESS
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde, David B. Allison, Donna H. Ryan, Craig A. Peterson, Barbara Troupin, Michael Schwiers, Wesley Day
The Lancet. 20111,055 Citations
Management of obesity
George A. Bray, Gema Frühbeck, Donna H. Ryan, John Wilding
The Lancet. 20161,009 Citations
Where is Pharmacology and Obesity Treatment research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Pharmacology and Obesity Treatment is open access?
ScholarIQopen access share
47%OPEN ACCESS
Gold
27%
Green
0%
Hybrid
7%
Bronze
13%
Closed
53%
Related on ScholarIQ
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
Paper
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Paper
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Paper
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Paper
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Paper
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Paper